National Expert Visits UC to Discuss Maternal-Fetal Surgery Debate
Larry Churchill, PhD, Ann Geddes Stahlman Chair of Medical Ethics at
Churchill will explore how religious convictions and optimistic expectations about maternal-fetal clinical trials can threaten the informed consent process and raise issues about recruitment and participation.
His talk will center on why parents agree to participate in a highly publicized and risky Vanderbilt clinical trial that uses innovative surgical techniques to treat fetuses with spina bifida lesions at 16 to 20 weeks gestation.
The surgery has recently drawn controversy and skepticism from the medical communityespecially neurosurgeonsand religious groups that question whether the benefits of the surgery outweigh the risks.
Religion is a powerful source of ethical norms that shapes interpretations and actions, says Churchill. Parents agreeing to participate in this highly controversial study displayed a lot of what I call common moral wisdomor reasoning through stories, parables, hunches or religious beliefs.
This, he says, raises questions about medical ethics and how physicians and clinical investigators should handle their patients religious views.
Churchill is widely published on the effects of medical ethics on human subjects, end of life decision making, social justice and
Churchill has a doctorate and a masters of divinity from
UCs Hutton Lectureship in Ethics, now in its third year, is an endowed lectureship named in honor of John Hutton, MD, former dean of the UC College of Medicine. Offered once a year, the lecture focuses on ethical topics facing todays health care system.
The lecture is free and open to the public, but reservations are encouraged. RSVP online at health.uc.edu/AlumniGiving/hutton.html or call (513) 558-0910.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.